261 related articles for article (PubMed ID: 17567701)
1. An attenuated strain of enterovirus 71 belonging to genotype a showed a broad spectrum of antigenicity with attenuated neurovirulence in cynomolgus monkeys.
Arita M; Nagata N; Iwata N; Ami Y; Suzaki Y; Mizuta K; Iwasaki T; Sata T; Wakita T; Shimizu H
J Virol; 2007 Sep; 81(17):9386-95. PubMed ID: 17567701
[TBL] [Abstract][Full Text] [Related]
2. Establishment of an animal challenge model as a potency assay for an inactivated Enterovirus Type 71 vaccine.
Wang KT; Lin SJ; Wang HC; Chen PC; Lin JJ; Chiang JR; Chang CL; Shih DY; Lo CF; Wang DY
Biologicals; 2016 Jul; 44(4):183-190. PubMed ID: 27068365
[TBL] [Abstract][Full Text] [Related]
3. A comparative study of multiple clinical enterovirus 71 isolates and evaluation of cross protection of inactivated vaccine strain FY-23 K-B in vitro.
Yang T; Li H; Yue L; Song X; Xie T; Ma S; Meng H; Zhang Y; He X; Long R; Yang R; Luo F; Xie Z; Li Q
Virol J; 2017 Oct; 14(1):206. PubMed ID: 29073897
[TBL] [Abstract][Full Text] [Related]
4. Identification and characterization of a cross-neutralization epitope of Enterovirus 71.
Liu CC; Chou AH; Lien SP; Lin HY; Liu SJ; Chang JY; Guo MS; Chow YH; Yang WS; Chang KH; Sia C; Chong P
Vaccine; 2011 Jun; 29(26):4362-72. PubMed ID: 21501643
[TBL] [Abstract][Full Text] [Related]
5. Cross-Antigenicity between EV71 Sub-Genotypes: Implications for Vaccine Efficacy.
Liu P; Yuan Y; Cui B; Huo Y; Bian L; Chen L; Liu S; Wang C; Xu Y; Tedcastle A; Gao F; Mao Q; Martin J; Liang Z
Viruses; 2021 Apr; 13(5):. PubMed ID: 33919184
[TBL] [Abstract][Full Text] [Related]
6. Temperature-sensitive mutants of enterovirus 71 show attenuation in cynomolgus monkeys.
Arita M; Shimizu H; Nagata N; Ami Y; Suzaki Y; Sata T; Iwasaki T; Miyamura T
J Gen Virol; 2005 May; 86(Pt 5):1391-1401. PubMed ID: 15831951
[TBL] [Abstract][Full Text] [Related]
7. Structure, Immunogenicity, and Protective Mechanism of an Engineered Enterovirus 71-Like Particle Vaccine Mimicking 80S Empty Capsid.
Wang X; Ku Z; Zhang X; Ye X; Chen J; Liu Q; Zhang W; Zhang C; Fu Z; Jin X; Cong Y; Huang Z
J Virol; 2018 Jan; 92(1):. PubMed ID: 29070691
[TBL] [Abstract][Full Text] [Related]
8. Immunity to avirulent enterovirus 71 and coxsackie A16 virus protects against enterovirus 71 infection in mice.
Wu TC; Wang YF; Lee YP; Wang JR; Liu CC; Wang SM; Lei HY; Su IJ; Yu CK
J Virol; 2007 Oct; 81(19):10310-5. PubMed ID: 17626076
[TBL] [Abstract][Full Text] [Related]
9. Partial protection against enterovirus 71 (EV71) infection in a mouse model immunized with recombinant Newcastle disease virus capsids displaying the EV71 VP1 fragment.
Ch'ng WC; Stanbridge EJ; Ong KC; Wong KT; Yusoff K; Shafee N
J Med Virol; 2011 Oct; 83(10):1783-91. PubMed ID: 21837796
[TBL] [Abstract][Full Text] [Related]
10. Enhanced neutralizing antibody response induced by inactivated enterovirus 71 in cynomolgus monkeys.
In HJ; Lim H; Lee JA; Lee SR; Jin YB; Jeong KJ; Hyeon JY; Yoo JS; Lee JW; Choi YK; Lee SW
PLoS One; 2018; 13(10):e0202552. PubMed ID: 30278051
[TBL] [Abstract][Full Text] [Related]
11. Cooperative effect of the attenuation determinants derived from poliovirus sabin 1 strain is essential for attenuation of enterovirus 71 in the NOD/SCID mouse infection model.
Arita M; Ami Y; Wakita T; Shimizu H
J Virol; 2008 Feb; 82(4):1787-97. PubMed ID: 18057246
[TBL] [Abstract][Full Text] [Related]
12. The Role of VP1 Amino Acid Residue 145 of Enterovirus 71 in Viral Fitness and Pathogenesis in a Cynomolgus Monkey Model.
Kataoka C; Suzuki T; Kotani O; Iwata-Yoshikawa N; Nagata N; Ami Y; Wakita T; Nishimura Y; Shimizu H
PLoS Pathog; 2015 Jul; 11(7):e1005033. PubMed ID: 26181772
[TBL] [Abstract][Full Text] [Related]
13. VP1 Amino Acid Residue 145 of Enterovirus 71 Is a Key Residue for Its Receptor Attachment and Resistance to Neutralizing Antibody during Cynomolgus Monkey Infection.
Fujii K; Sudaka Y; Takashino A; Kobayashi K; Kataoka C; Suzuki T; Iwata-Yoshikawa N; Kotani O; Ami Y; Shimizu H; Nagata N; Mizuta K; Matsuzaki Y; Koike S
J Virol; 2018 Aug; 92(15):. PubMed ID: 29848582
[TBL] [Abstract][Full Text] [Related]
14. Neutralizing antibodies induced by recombinant virus-like particles of enterovirus 71 genotype C4 inhibit infection at pre- and post-attachment steps.
Ku Z; Ye X; Huang X; Cai Y; Liu Q; Li Y; Su Z; Huang Z
PLoS One; 2013; 8(2):e57601. PubMed ID: 23451250
[TBL] [Abstract][Full Text] [Related]
15. Enterovirus type 71 neutralizing antibodies in the serum of macaque monkeys immunized with EV71 virus-like particles.
Lin YL; Yu CI; Hu YC; Tsai TJ; Kuo YC; Chi WK; Lin AN; Chiang BL
Vaccine; 2012 Feb; 30(7):1305-12. PubMed ID: 22214888
[TBL] [Abstract][Full Text] [Related]
16. Protective effect of enterovirus‑71 (EV71) virus‑like particle vaccine against lethal EV71 infection in a neonatal mouse model.
Cao L; Mao F; Pang Z; Yi Y; Qiu F; Tian R; Meng Q; Jia Z; Bi S
Mol Med Rep; 2015 Aug; 12(2):2473-80. PubMed ID: 25936344
[TBL] [Abstract][Full Text] [Related]
17. A new EV71 VP3 epitope in norovirus P particle vector displays neutralizing activity and protection in vivo in mice.
Jiang L; Fan R; Sun S; Fan P; Su W; Zhou Y; Gao F; Xu F; Kong W; Jiang C
Vaccine; 2015 Nov; 33(48):6596-603. PubMed ID: 26529072
[TBL] [Abstract][Full Text] [Related]
18. A virus-like particle based bivalent vaccine confers dual protection against enterovirus 71 and coxsackievirus A16 infections in mice.
Ku Z; Liu Q; Ye X; Cai Y; Wang X; Shi J; Li D; Jin X; An W; Huang Z
Vaccine; 2014 Jul; 32(34):4296-303. PubMed ID: 24950363
[TBL] [Abstract][Full Text] [Related]
19. Enterovirus-Specific Anti-peptide Antibodies.
Poh CL; Kirk K; Chua HN; Grollo L
Methods Mol Biol; 2015; 1348():341-50. PubMed ID: 26424285
[TBL] [Abstract][Full Text] [Related]
20. Optimization of microcarrier cell culture process for the inactivated enterovirus type 71 vaccine development.
Wu SC; Liu CC; Lian WC
Vaccine; 2004 Sep; 22(29-30):3858-64. PubMed ID: 15364432
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]